Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of ILAE
Refer for surgical evaluation sooner than you think!
@IlaeWeb @LaraJehiMD Sam Wiebe https://t.co/lVGKJDbBKx
#RNS, #DBS, #VNS - which to choose for drug resistant #epilepsy when resection/ablation isn't the best option? New analysis from the @IlaeWeb Surgical Therapies Commission in @EpilepsiaJourn. Neuromodulation is increasing the # of candidates eligible for surgery.
@AmEpilepsySoc
ILAE has launched a database of global health projects in #epilepsy in order to identify & connect professionals working in #epilepsyresearch, teaching & service internationally, including those working to reduce the global epilepsy treatment gap. https://t.co/ewcPpXfsiJ
Patients with Epilepsy have a higher cardiac readmission rate 🫀 when compared to those suffering from other neurological disease such as Multiple Sclerosis 🧠
@churlsu@EpilepsyBehavi1
Check our article!
https://t.co/FWdJOA4Isc
Our ILAE report on epilepsy care during the COVID pandemic. Increased psychological distress, seizures and difficulty accessing medical care. Need to ensure ongoing support to prevent a parallel pandemic of unmet health care needs. https://t.co/HgR6gzqPf7
Looking for a full-time Research Assistant for #BIENlab 2021/22 to help with brain network research @VUMC_Neurosurg. Great for graduating seniors taking gap year(s) to gain experience before grad/med school. Please RT! Details: https://t.co/ErMFCUSAxX
Missing the target—On https://t.co/SAOYBJb7e3, 53% of #COVID19 treatment trials, and 100% of vaccine trials at high risk to exclude older adults. Planning, staff training, and aging expertise would help achieve trials that are relevant and inclusive https://t.co/zyTmv920Ae
Our study lead by @sharon_inouye. Older adults who are the target pop of COVID-19, must be included in any clinical trial of treatments/vaccines. The Exclusion of Older Persons From Vaccine and Treatment Trials for COVID-19 https://t.co/d3ztmrHYms @JAMAInternalMed@JAMA_current
"Our findings indicate that older adults are likely to be excluded from more than 50% of #COVID19 clinical trials and 100% of vaccine trials."
"meaning there would be no or few participants over age 75."
https://t.co/74oq7lQV7b @JAMAInternalMed@sharon_inouye
Study conducted by my colleagues and I, led by the fantastic Dr. Correa. Correct information and resources need to be made available for those with TBI/epilepsy re their condition and important research. @NeuroMonteEinst@MSHSNeurology
Quantitative readability analysis of websites providing information on traumatic brain injury and epilepsy: A need for clear communication. --
Thankful for the opportunity to get advocate for better #healtheducation for #TBI and #epilepsy.
https://t.co/jZfxk6EgUu
Great day for #Epilepsy yesterday at #WHO Executive Board. Powerful statements from many countries and from #ILAE and #IBE. Overwhelming positive response of #WHO Member States for #Epilepsy. Another milestone for #Epilepsy. Thanks to All.
My colleagues and I will be speaking about innovation & improvement in health care at the International Leadership Development Program for Physicians @HarvardChanECPE. Spend a day at @AriadneLabs to see how we drive change within health care! Register → https://t.co/vq2A2iifvR
Future studies using a quantitative cost-benefit framework are needed to determine the cost-effectiveness of advanced diagnostic tests (beyond MRI) in the epilepsy presurgical evaluation. @MountSinaiNeuro@NeurosurgUCSF https://t.co/hw8enY4x4C